INTS
Intensity Therapeutics, Inc. Common stock
NASDAQ: INTS · HEALTHCARE · BIOTECHNOLOGY
$5.21
+0.06% today
Updated 2026-05-06
Market cap
$13.80M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.56
Dividend yield
—
52W range
$5 – $44
Volume
0.0M
Intensity Therapeutics, Inc. Common stock (INTS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |